⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Intro Bio Pharma Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Intro Bio Pharma Inc.
↗Pyeongtaek-si, South Korea
Intro Bio Pharma Inc. is a South Korean pharmaceutical company specializing in R&D, manufacturing, and technical transfer of pharmaceutical products. The company operates PIC/S GMP-certified facilities and provides comprehensive solutions including contract manufacturing (CMO), quality control, and the development of new and incrementally modified drugs.
Established in 2007, the company focuses on various dosage forms such as tablets, capsules, and granules. It serves as a partner for bio-ventures and pharmaceutical firms that require manufacturing and development support, maintaining in-house capabilities from initial research to final production.
CLASSIFICATION
Company Type:CDMO
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:CMO/CDMO and Generic Drug Development
SIZE & FINANCIALS
Employees:51-200
Founded:2007
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Chengdu Medicare Technology (Technical transfer contract)
COMPETITION
Position:Niche Player
LEADERSHIP
Key Executives:
Suk Yong Park - CEO
LINKS
Website:intropharm.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Intro Bio Pharma Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.